Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Sam Altman has tapped Mikhail Shapiro, an award-winning biomolecular engineer, to join the Merge Labs brain-computer ...

OpenAI is working on something big, developing its own brain-computer interface. But what does this actually mean?

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in ...

Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...

The post Sam Altman Reportedly Developing Noninvasive Brain Interface to Rival Elon Musk’s Neuralink appeared first on ...

The National Reconstruction Fund Corporation (NRFC) has taken a $54 million stake in Australian medical device company Synchron, to support the production of minimally invasive Brain-Computer ...

These are exciting times at the intersection of artificial intelligence (AI) and neuroscience. The trend in brain-computer interfaces (BCIs) is toward flexible and less invasive devices that can ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.